Respironics buy puts Philips at forefront of home healthcare sector
This article was originally published in Clinica
Executive Summary
Dutch electronics giant Philips is kickstarting the new year with a Euro3.6bn ($5.1bn) deal to acquire all the shares of US sleep and respiratory therapy developer Respironics, making it the group's biggest acquisition ever.